DIAMOND Research Programme
diamond-derx.bsky.social
Innovating Methods | Advancing Deprescribing Based at RCSI (https://bsky.app/profile/rcsi.bsky.social), led by Prof Frank Moriarty (@frankmoriarty.bsky.social) and funded by Wellcome. Find out more about our work here: https://diamond-deprescribing.eu/
👤 Joined on 11 February 2025
83
Followers
188
Following
73
Total Posts
📜 Kullanıcı Geçmişi
- 11 Kas 2024, 22:05
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@diamond-derx.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
Our first paper from the @diamond-derx.bsky.social research programme funded by @wellcometrust.bsky.social is out! We sought to understand how simulation studies in pharmacoepidemiology have been conducted, led by Dr Ryan Muddiman @rcsi.bsky.social
Show PostJust ten days left to apply for this Research Fellow position, focused on pharmacoepidemiology and deprescribing. More information about the DIAMOND programme available at: diamond-deprescribing.eu Full job description here (deadline July 7th): my.corehr.com/pls/rcsirecr...
Show Post
#deprescribing needs careful monitoring. This week, restarted medication (albeit at lower doses than originally taking) for 2 patients whose symptoms worsened after stopping. A deprescribing success - found out the medication likely helping more than harming; now will assess response to confirm.
Show Post
New study reports facilitators and barriers to pharmacist-led antihypertensive deprescribing in LTC. Top barriers include structural barriers, time and lack of support, raising a need for greater interprof. collab. and public awareness of deRXing. onlinelibrary.wiley.com/doi/10.1111/...
Show Post
Combining physician academic detailing with patient previsit activation increased diabetes medication deprescribing among older patients with type 2 diabetes. https://ja.ma/4ecZ31S
Show Post